Overview of Dr. Slovin
Dr. Susan Slovin is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, New York-Presbyterian Hospital, and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from Sidney Kimmel Medical College at Thomas Jefferson University and has been in practice 27 years. Dr. Slovin accepts several types of health insurance, listed below. She is one of 497 doctors at Memorial Sloan Kettering Cancer Center and one of 375 doctors at New York-Presbyterian Hospital who specialize in Oncology. She has more than 100 publications and over 500 citings.
Office
353 East 68th Street
New York, NY 10065
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1993 - 1996
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1990 - 1993
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1990
- Columbia University Graduate School of Arts & SciencesM.Phil., Pathobiology, 1974 - 1978
- Columbia University Graduate School of Arts & SciencesPh.D., Pathobiology, 1974 - 1978
- Barnard CollegeA.B., Biology, 1970 - 1974
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 1991 - 2026
- NJ State Medical License 2019 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Patient’s Choice Award Vitals, 2015
- Top Doctors: New York Metro Area Castle Connolly, 2004-2014
- Cited in America’s Top Doctors 2012-2013
- Join now to see all
Clinical Trials
- Biological Therapy in Treating Patients With Prostate Cancer Start of enrollment: 1995 Jan 01
- Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer Start of enrollment: 1998 Jun 01
- Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer Start of enrollment: 1999 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsMicrosatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer.Andrew T Lenis, Vignesh Ravichandran, Samantha Brown, Syed M Alam, Andrew Katims
Clinical Cancer Research. 2024-09-03 - Clinical, Imaging, and Technical Factors Associated with Successful Genomic Profiling of Bone Biopsy Tissue in Prostate Cancer.Fourat Ridouani, H Alberto Vargas, Daniel J Holzwanger, Heiko Schöder, Emily Waters
European Urology Oncology. 2024-08-01 - 1 citationsRandomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer.Susan F Slovin, Karen Knudsen, Susan Halabi, Renee de Leeuw, Ayesha Shafi
Journal of Clinical Oncology. 2023-11-10
Journal Articles
- Biomarkers for Immunotherapy in Genitourinary MalignanciesSlovin SF, Urologic Oncology: Seminars and Original Investigations, 1/16/2015
- Androgen Deprivation Therapy for Prostate Cancer – Friend or Foe to the Psyche?Slovin SF, J Clin Onc, 1/11/2015
- Immunotherapeutic Approaches in Prostate Cancer, Combinations, and Clinical Integration, ASCO Educational BookSlovin SF, Am Soc Clin Oncol, 1/1/2015
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Traversing the Glycan Pathway.Slovin, SF, American Society of Clinical Oncology, Chicago, IL, 1/30/2008
- Preventing Osteoporosis in the Androgen-Deprived State - Do SERMS Really Rate?Slovin, SF, Late Breaking Abstracts; American Assoc of Cancer Res, San Diego, CA, 1/12/2008
Lectures
- A multicenter, randomized, controlled trial comparing the occurrence of major adverse cardiovascular events (MACEs) in patients (pts) with prostate cancer (pc) and car...2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Prostate cancer immunotherapy: Here to stay or over and out?Maimonides Medical Center, Brooklyn, NY - 1/27/2015
- Biomarkers for genitourinary malignancies: prime or choice?Memorial Sloan-Kettering Cancer Center, New York, NY - 1/27/2015
- Join now to see all
Other
- Better Bone Health for Men Living with Prostate CancerSlovin S, and Partington, EW, CANCERcare Connect TM Patient Monograph
1/1/2005 - Cancer Immunotherapeutics - CHI Meeting (Part III)Slovin, SF, IDDB Meeting Report 2
Boston, MA - 1/20/2004 - Biochemical relapse in prostate cancer: is PSA promoting stress and anxiety?Slovin, SF, Medscape Hematology-Oncology e-Journal
1/1/2002 - Join now to see all
Press Mentions
- Cardiovascular Disease and Androgen Axis–Targeted Drugs for Prostate CancerMay 29th, 2020
- Connections’ Launches ADT in Prostate Cancer: Managing Cardiovascular Risk Video SeriesJuly 12th, 2019
- OncLive® Presents Its Latest State of the Science Summit™ on Genitourinary CancersNovember 20th, 2018
- Join now to see all
Grant Support
- Developing T Cell Clones Cytotoxic To SarcomasNational Cancer Institute1985
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS California PPO
Blue Shield California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
Great West PPOHealth Net California Large Group PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PHCS PPO - Kaiser
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: